- Eric Terry | May 21, 2012 8:00 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
A preliminary study performed at the Tehran University of Medical Sciences suggests that adding pioglitazone (Actos) to a commonly prescribed anti-depressant, citalopram (Celexa), boosts the...
- Eric Terry | May 18, 2012 3:15 PM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Takeda Pharmaceutical received more bad news last week when the FDA requested more information with regards to its new Type2 Diabetes Drug chemically knows as alogliptin and currently marketed in...
- Tor Hoerman | April 24, 2012 4:44 PM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Takeda’s Type2 Diabetes drug, Actos (pioglitazone) has been the subject of FDA warnings as a result of its link to an increased risk of bladder cancer amongst patients who use the drug the...
- Jacob Plattenberger | March 30, 2012 10:30 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Alert Day, sponsored by the American Diabetes Association, was created to raise Americans’ awareness of their risks of developing type-2 diabetes. Celebrated earlier this week, Alert Day...
- Tor Hoerman | March 13, 2012 10:44 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Did Takeda downplay reports of bladder cancer and congestive heart failure in Actos patients? Helen Ge, former Takeda medical reviewer, accuses the Japanese pharmaceutical company of exactly that...
- Tor Hoerman | March 01, 2012 11:34 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Since filing the first Cook County Actos case against Takeda Pharmaceutical, the attorneys at TorHoerman Law, in cooperation with other leading law firms, have been working diligently to...
- John M. Restaino | October 31, 2011 10:34 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
Actos (pioglitazone) is an oral diabetes medication in the class of drugs known as the thiazolidinediones (TZD). Diabetes is a disease in which the pancreas does not make enough insulin to control...
- Eric Terry | September 20, 2011 10:50 AM | Chicago-Land, IL
Category:
FDA & Prescription Drugs
The FDA warns of increased bladder cancer risk associated with the use of the diabetes drug Actos (pioglitazone).
This warning comes after a review of data from a five-year interim analysis...